Sutro Biopharma is a biopharmaceutical company advancing a next-generation antibody-drug conjugate (ADC) platform designed to deliver single- and dual-payload ADCs that enable meaningful breakthroughs for patients with cancer.
Sutro Biopharma is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies. The Senior Director, Clinical Operations is responsible for ensuring the integrity and success of Sutro’s clinical trials, aligning Clinical Operation goals with organizational objectives.
Sutro Biopharma is a biopharmaceutical company advancing a next-generation antibody-drug conjugate (ADC) platform designed to deliver single- and dual-payload ADCs that enable meaningful breakthroughs for patients with cancer.
Janux Therapeutics